Cyprodenate

{{Short description|Chemical compound}}

{{Drugbox

| Watchedfields = changed

| verifiedrevid = 444141768

| IUPAC_name = 2-dimethylaminoethyl 3-cyclohexylpropanoate

| image = Cyprodenate.svg

| image_class = skin-invert-image

| width = 200

| tradename =

| Drugs.com = {{drugs.com|international|cyprodenate}}

| routes_of_administration =

| CAS_number_Ref = {{cascite|correct|??}}

| CAS_number = 15585-86-1

| ATC_prefix = N06BX04

| PubChem = 71875

| DrugBank_Ref = {{drugbankcite|correct|drugbank}}

| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}

| ChemSpiderID = 64892

| ChEMBL = 2106590

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = I44VIC13P8

| KEGG_Ref = {{keggcite|correct|kegg}}

| KEGG = D07764

| C=13 | H=25 | N=1 | O=2

| smiles = CN(C)CCOC(=O)CCC1CCCCC1

| StdInChI_Ref = {{stdinchicite|correct|chemspider}}

| StdInChI = 1S/C13H25NO2/c1-14(2)10-11-16-13(15)9-8-12-6-4-3-5-7-12/h12H,3-11H2,1-2H3

| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}

| StdInChIKey = MPOYJPINNSIHAK-UHFFFAOYSA-N

}}

Cyprodenate (Actebral) is a stimulant drug.{{cite journal | vauthors = Dormard Y, Levron JC, Le Fur JM | title = Pharmacokinetic study of maleate acid of 2-(N,N-dimethylaminoethanol-14C1)-cyclohexylpropionate (cyprodenate) and of N,N-dimethylaminoethanol-14C1 in animals | journal = Arzneimittel-Forschung | volume = 25 | issue = 2 | pages = 201–7 | date = February 1975 | pmid = 1173033 }} It was used for counteracting the effects of benzodiazepine tranquillizer drugs before the development of newer antidotes such as flumazenil.{{cite journal | vauthors = Bobkov I, Morozov IS | title = [Correction of psychodepressive effects of benzodiazepine tranquilizers by administration of psychostimulants] | language = English | journal = Biulleten' Eksperimental'noi Biologii I Meditsiny | volume = 94 | issue = 10 | pages = 48–51 | date = October 1982 | pmid = 6129008 | doi = 10.1007/BF00827201 | s2cid = 19153614 }} It produces dimethylethanolamine as a metabolite.{{citation needed|date=September 2018}}